Magnesium modulates the expression levels of calcification-associated factors to inhibit calcification in a time‑dependent manner

Experimental and Therapeutic Medicine

Volumn 9, Issue 3, 2015, Pages 1028-1034

  Xu, Jinsheng ^a   Bai, Yaling ^a   Jin, Jingjing ^a   Zhang, Junxia ^a   Zhang, Shenglei ^a   Cui, Liwen ^a   Zhang, Huiran ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Core binding factor 1; Magnesium; Matrix Gla protein; Osteopontin; Time dependent manner; Vascular calcification

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; ALIZARIN RED S; ALKALINE PHOSPHATASE; CALCIUM; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCEROL 2 PHOSPHATE; MAGNESIUM; MAGNESIUM SULFATE; MONOCLONAL ANTIBODY; OSTEOCALCIN; OSTEOPONTIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL CALCIFICATION; CELL CULTURE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; MALE; MRNA EXPRESSION ASSAY; NONHUMAN; PHASE CONTRAST MICROSCOPY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STAINING; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 84922041801     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2215     Document Type: Article

References (30)

1. Foley RN and Parfrey PS: Cardiovascular disease and mortality in ESRD. J Nephrol 11: 239-245, 1998.
2. Goodman WG, Goldin J, Kuizon BD, et al: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000.
3. Blacher J, Guerin AP, Pannier B, Marchais SJ and London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38: 938-942, 2001.
4. Scatena M, Liaw L and Giachelli CM: Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27: 2302-2309, 2007.
5. O'Neill WC: Mineral complexes and vascular calcification. Kidney Int 76: 915-916, 2009.
6. Zarjou A, Jeney V, Arosio P, et al: Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. J Am Soc Nephrol 20: 1254-1263, 2009.
7. Geiger H and Wanner C: Magnesium in disease. Clin Kidney J 5 (Suppl 1): i25-i38, 2012.
8. Spiegel DM and Farmer B: Long-term effects of magnesium carbonate on coronary artery calcification and bone mineral density in hemodialysis patients: a pilot study. Hemodial Int 13: 453-459, 2009.
9. Massy ZA and Drüeke TB: Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J 5 (Suppl 1): i52-i61, 2012.
10. Louvet L, Büchel J, et al: Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant 28: 869-878, 2013.
11. Kircelli F, Peter ME, Sevinc Ok E, et al: Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 27: 514-521, 2012.
12. Cai Y, Teng X, Pan CS, Duan XH, Tang CS and Qi YF: Adrenomedullin up-regulates osteopontin and attenuates vascular calcification via the cAMP/PKA signaling pathway. Acta Pharmacol Sin 31: 1359-1366, 2010.
13. Carbone L: Pain management standards in the eighth edition of the Guide for the Care and Use of Laboratory Animals. J Am Assoc Lab Anim Sci 51: 322-328, 2012.
14. Mizobuchi M, Towler D and Slatopolsky E: Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 20: 1453-1464, 2009.
15. Pun PH, Smarz TR, Honeycutt EF, Shaw LK, Al-Khatib SM and Middleton JP: Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int 76: 652-658, 2009.
16. Tzanakis I, Pras A, Kounali D, et al: Mitral annular calcifications in haemodialysis patients: a possible protective role of magnesium. Nephrol Dial Transplant 12: 2036-2037, 1997.
17. Tzanakis I, Virvidakis K, Tsomi A, et al: Intra-and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res 17: 102-108, 2004.
18. Turgut F, Kanbay M, Metin MR, Uz E, Akcay A and Covic A: Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 40: 1075-1082, 2008.
19. Montezano AC, Zimmerman D, Yusuf H, et al: Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 56: 453-462, 2010.
20. Jono S, McKee MD, Murry CE, et al: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87: E10-E17, 2000.
21. Sun Y, Byon CH, Yuan K, et al: Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ Res 111: 543-552, 2012.
22. Zhong H, Liu F, Dai X, Zhou L and Fu P: Sodium thiosulfate protects human aortic smooth muscle cells from osteoblastic transdifferentiation via high-level phosphate. Kaohsiung J Med Sci 29: 587-593, 2013.
23. Steitz SA, Speer MY, Curinga G, et al: Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 89: 1147-1154, 2001.
24. Moe SM, Duan D, Doehle BP, O'Neill KD and Chen NX: Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 63: 1003-1011, 2003.
25. Luo G, Ducy P, McKee MD, et al: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386: 78-81, 1997.
26. Boström K, Tsao D, Shen S, Wang Y and Demer LL: Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 276: 14044-14052, 2001.
27. Wada T, McKee MD, Steitz S and Giachelli CM: Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 84: 166-178, 1999.
28. Speer MY, McKee MD, Guldberg RE, et al: Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196: 1047-1055, 2002.
29. He Y, Yao G, Savoia C and Touyz RM: Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: role of angiotensin II. Circ Res 96: 207-215, 2005.
30. Paravicini TM, Chubanov V and Gudermann T: TRPM7: a unique channel involved in magnesium homeostasis. Int J Biochem Cell Biol 44: 1381-1384, 2012.